Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Triad Isotopes

Triad Isotopes
2007 FOUNDED
M&A STATUS
501-600 EMPLOYEES
M&A LATEST DEAL TYPE
5 FINANCING ROUNDS
7 INVESTMENTS
Description

Developer and marketer of nuclear pharmaceuticals. The company's radio pharmaceuticals used for both diagnostic imaging procedures, enable the hospitals and nuclear medicine operators to diagnose and treat patients, primarily those with cardiac and cancer concerns.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Jubilant Draximage
Primary Office
  • 4205 Vineland Road
  • Suite L1
  • Orlando, FL 32811
  • United States

+1 (407) 000-0000

Triad Isotopes Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Triad Isotopes‘s full profile, request access.

Request full access to PitchBook

Triad Isotopes Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Navidea Biopharmaceuticals Corporation Dublin, OH 00 00000 000000000 00 00000
0000000 0000000000 Venture Capital-Backed Sydney, Australia 0 00.00 0000000000 0 00.00
To view this company’s complete list of competitors, request access »

Triad Isotopes Investments (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (00 00000 01-May-2010 0000000000 Pharmaceuticals 0000000 00000
00000000 0000000 0 08-Nov-2007 0000000000 Monitoring Equipment 0000000 00000
000 000 00000000 08-Nov-2007 0000000000 Clinics/Outpatient Services 0000000 00000
0000000000 0000000 03-Oct-2007 0000000000 Monitoring Equipment 0000000 00000
Coastal Nuclear Pharmacy 16-Jan-2007 Buyout/LBO Pharmaceuticals
To view this company’s complete investment and acquisition history, request access »

Triad Isotopes Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Triad Isotopes‘s full profile, request access.

Request full access to PitchBook

Triad Isotopes Executive Team (6)

Name Title Board
Seat
Contact
Info
Domenic Meffe Chief Executive Officer & President
Claudia Griffiths Co-Chief Financial Officer & Senior Vice President
Jonathan Lucas Co-Chief Financial Officer
William Cox Executive
Steve Putnal Senior Member of Management Team

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »